Compounds > n-phenylphthalimide

Page last updated: 2024-08-24

n-phenylphthalimide and thalidomide

n-phenylphthalimide has been researched along with thalidomide in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azuma, A; Hashimoto, Y; Kato, F; Kato, M; Kobayashi, Y; Miyachi, H; Ogasawara, A; Uchimura, E; Watanabe, N	1
Hashimoto, Y; Nagasawa, K; Noguchi, T; Shimazawa, R	1
Hashimoto, Y; Iguchi, T; Inatsuki, S; Kizaki, M; Kobayashi, H; Miyachi, H; Noguchi, T; Oda, S	1
Fujimoto, H; Hashimoto, Y; Miyachi, H; Miyajima, A; Noguchi, T; Sano, H	1
Hashimoto, Y; Miyachi, H; Noguchi, T; Sano, H; Tanatani, A	1
Hashimoto, Y; Ishikawa, M; Motoshima, K; Sugita, K	1
Aoyama, H; Hashimoto, M; Hashimoto, Y; Ishikawa, M; Tetsuhashi, M	1

Other Studies

7 other study(ies) available for n-phenylphthalimide and thalidomide

Article	Year
Novel biological response modifiers: phthalimides with tumor necrosis factor-alpha production-regulating activity. Journal of medicinal chemistry, 1997, Aug-29, Volume: 40, Issue:18 Topics: Cell Survival; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunologic Factors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Okadaic Acid; Optical Rotation; Phthalimides; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	1997
Thalidomide and its analogues as cyclooxygenase inhibitors. Bioorganic & medicinal chemistry letters, 2002, Apr-08, Volume: 12, Issue:7 Topics: Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inhibitory Concentration 50; Isoenzymes; Membrane Proteins; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Substrate Specificity; Thalidomide	2002
Tubulin-polymerization inhibitors derived from thalidomide. Bioorganic & medicinal chemistry letters, 2005, Jan-17, Volume: 15, Issue:2 Topics: Colchicine; Indoles; Isoindoles; Lactones; Macrolides; Nerve Tissue Proteins; Thalidomide; Time Factors; Tubulin; Tubulin Modulators	2005
Angiogenesis inhibitors derived from thalidomide. Bioorganic & medicinal chemistry letters, 2005, Dec-15, Volume: 15, Issue:24 Topics: Angiogenesis Inhibitors; Endothelium, Vascular; Humans; Structure-Activity Relationship; Thalidomide; Umbilical Veins	2005
N-phenylphthalimide-type cyclooxygenase (COX) inhibitors derived from thalidomide: substituent effects on subtype selectivity. Chemical & pharmaceutical bulletin, 2004, Volume: 52, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Phthalimides; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Substrate Specificity; Thalidomide	2004
Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists. Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:9 Topics: Animals; Enzyme Inhibitors; Glycogen Phosphorylase, Liver Form; Glycogen Phosphorylase, Muscle Form; Glycoside Hydrolase Inhibitors; Liver X Receptors; Orphan Nuclear Receptors; Phthalimides; Rabbits; Thalidomide	2009
Development of tryptase inhibitors derived from thalidomide. Bioorganic & medicinal chemistry, 2010, Jul-15, Volume: 18, Issue:14 Topics: Enzyme Inhibitors; Humans; Models, Molecular; Phthalimides; Thalidomide; Tryptases	2010